Gregor Rozenberg

Queensland BioCapital Funds Pty Ltd. (QBF) is the venture capital arm of Queensland Investment Corporation, a Queensland Government-owned corporation. QBF established in 2002, located in Australia.

Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA.

Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia.

Columna AB provides IT consulting services. It provides IT solutions within the road transportation sector. Columna develops solutions with the National Road Database (NVDB) and a European cooperation as a base. The company also provides real time traffic information such as road and weather conditions, temperatures and general traffic information. The company is headquartered in Borlange, Sweden.

Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia.

Part of TUI AG, Adventure Co. is a travel agency specializing in adventure holidays. The company is based in Hampshire, UK. Adventure was acquired by First Choice Holidays Plc from Ebookers Ltd. on March 11, 2004 for $5.58 million.

Broadband Networks, Inc. provides optical networking solutions. It specializes in photonics, electronics, data networking, carrier-class telecommunications solutions, and carrier-class management software design. RBN was founded by Roger Buckeridge and Ross Halgren in 1999 and is headquartered in Kennesaw, GA.

Columna Pty Ltd. designs and produces invasive technologies for spinal surgery. The firm focuses on spinal, neuro, and orthopedic products for the purpose of averting and controlling pain and dysfunction caused by degeneration of the spine. It has offices in Australia and the United States. The company was founded in 2001 and is headquartered in Kogarah, Australia.